<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>MedCity INVEST PharmaTech</provider_name><provider_url>https://events.medcitynews.com/invest-pharmatech</provider_url><author_name>Laura Kittredge</author_name><author_url>https://events.medcitynews.com/invest-pharmatech/author/lkittredge/</author_url><title>Steven Collens - MedCity INVEST PharmaTech</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="lMVamR2wNk"&gt;&lt;a href="https://events.medcitynews.com/invest-pharmatech/speakers/steven-collens/"&gt;Steven Collens&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://events.medcitynews.com/invest-pharmatech/speakers/steven-collens/embed/#?secret=lMVamR2wNk" width="600" height="338" title="&#x201C;Steven Collens&#x201D; &#x2014; MedCity INVEST PharmaTech" data-secret="lMVamR2wNk" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://events.medcitynews.com/invest-pharmatech/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://events.medcitynews.com/uploads/sites/3/2017/06/SteveCollens.jpg</thumbnail_url><thumbnail_width>189</thumbnail_width><thumbnail_height>200</thumbnail_height><description>Steven Collens is CEO of MATTER, Chicago&#x2019;s healthcare technology incubator. He also serves as senior advisor to Pritzker Group Venture Capital. Prior to assuming his current role, Collens was SVP at Pritzker Group, the investment firm led by Tony and J.B. Pritzker. In that capacity, he led the team that created 1871, Chicago&#x2019;s center for&hellip;</description></oembed>
